NR4A1 and breast carcinoma: We identified patients aged 70 to 90 years old newly diagnosed in 2010–2015 with early‐stage, hormone receptor positive, and human epidermal growth factor receptor 2 (HER2) negative (HR+/Her2−) breast cancer who received lumpectomy and omitted radiation therapy using the SEER‐Medicare database.